Tuesday, September 3, 2019

Hepcidin and its therapeutic potential in neurodegenerative disorders

›
Qian, Z‐M, Ke, Y.; Med Res Rev. 2019; 1‐ 21. Doi:10.1002/med.21631 Reducing iron toward normal levels or hampering the increases in iron ...
Monday, September 2, 2019

Multifunctional radical quenchers as potential therapeutic agents for the treatment of mitochondrial dysfunction

›
Xun Ji, Omar M Khdour & Sidney M Hecht; FUTURE MEDICINAL CHEMISTRYVOL. 11, NO. 13; Published Online:30 Aug 2019 doi:10.4155/fmc-2018-048...
Sunday, September 1, 2019

The Working Life of People with Degenerative Cerebellar Ataxia

›
A. Ranavolo, M. Serrao, T. Varrecchia, C. Casali, A. Filla, A. Roca, A. Silvetti, C. Marcotulli, B. M. Rondinone, S. Iavicoli, F. Draicchio;...
Saturday, August 31, 2019

Very-late-onset Friedreich’s ataxia: diagnosis in a kindred with late-onset cerebellar ataxia

›
Conor Fearon, Roisin Lonergan, Damien Ferguson, Susan Byrne, David Bradley, Yvonne Langan, Janice Redmond; Practical Neurology Published Onl...
Thursday, August 29, 2019

Iron Pathophysiology in Friedreich’s Ataxia

›
Li K. (2019) Iron Pathophysiology in Friedreich’s Ataxia. In: Chang YZ. (eds) Brain Iron Metabolism and CNS Diseases. Advances in Experiment...
Wednesday, August 28, 2019

Oral mobility reflects rate of progression in advanced Friedreich’s ataxia

›
Borel, S. , Gatignol, P. , Smail, M. , Monin, M. , Ewenczyk, C. , Bouccara, D. and Durr, A. (2019). Ann Clin Transl Neurol. doi:10.1002/acn3...
Friday, August 23, 2019

Application of Quantitative Motor Assessments in Friedreich Ataxia and Evaluation of Their Relation to Clinical Measures

›
Christian Hohenfeld, Imis Dogan, Robin Schubert, Claire Didszun, Ludger Schöls, Matthis Synofzik, Ilaria A. Giordano, Thomas Klockgether, Jö...
Saturday, August 17, 2019

Measuring peripheral nerve involvement in Friedreich’s ataxia

›
Creigh, P. D., Mountain, J. , Sowden, J. E., Eichinger, K. , Ravina, B. , Larkindale, J. and Herrmann, D. N. (2019). Ann Clin Transl Neurol....

Exicure, Inc.Announced important preclinical data supporting development of SNA technology in the central nervous system (CNS)

›
Exicure, Inc. (Nasdaq: XCUR), 8 Aug 2019, pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) co...
Thursday, August 15, 2019

Mitochondrial disorders and drugs: what every physician should know

›
Orsucci D, Caldarazzo Ienco E, Siciliano G, Mancuso M.; Drugs in Context 2019; 8: 212588. DOI: 10.7573/dic.212588 In this review we discus...